Home
>
National Drug Code (NDC)
>
Maxiphen DM
Maxiphen DM - 58605-423-02 - (Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide)
Drug Information of Maxiphen DM
| Product NDC: | 58605-423 |
| Proprietary Name: | Maxiphen DM |
| Non Proprietary Name: | Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
| Active Ingredient(s): | 20; 400; 10 mg/1; mg/1; mg/1 & nbsp; Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Maxiphen DM
| Product NDC: | 58605-423 |
| Labeler Name: | MCR American Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20080331 |
Package Information of Maxiphen DM
| Package NDC: | 58605-423-02 |
| Package Description: | 20 TABLET in 1 BLISTER PACK (58605-423-02) |
NDC Information of Maxiphen DM
| NDC Code | 58605-423-02 |
| Proprietary Name | Maxiphen DM |
| Package Description | 20 TABLET in 1 BLISTER PACK (58605-423-02) |
| Product NDC | 58605-423 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080331 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | MCR American Pharmaceuticals, Inc. |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 20; 400; 10 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
